Sovateltide

Sovateltide is a specialised injection used to treat acute ischemic stroke. An acute ischemic stroke occurs when a blood clot blocks blood flow to part of the brain, reducing oxygen supply and damaging brain cells. Its primary medical purpose is to protect brain cells from permanent damage after a sudden blockage of blood flow to the brain. By targeting specific receptors in the central nervous system, this medicine helps limit the extent of brain injury during this critical medical emergency.

This medicine is typically given as a short series of intravenous injections over a few days in a hospital. Treatment should be started within the specified time window after an acute ischaemic stroke, as decided by your doctor.

Food intake does not affect how it works. Combining this treatment with early physical rehabilitation and a low-sodium, heart-healthy diet can significantly improve long-term recovery outcomes.

While many patients tolerate the therapy well, some may experience mild side effects like headaches, temporary dizziness, or irritation at the injection site. However, you must inform your doctor immediately if you experience severe symptoms such as breathing difficulties, rapid blood pressure changes, or signs of an allergic reaction.

Before receiving this injection, talk to your doctor if you have a history of bleeding disorders, recent major surgeries, or severe liver damage. Do not take this if you have a known allergy to this medicine or any of its inactive ingredients.

Because this treatment is managed in a hospital, your medical team will monitor for interactions with blood thinners or other medications that could increase bleeding risks. It is also vital to consult your doctor if the patient is pregnant, breastfeeding, or elderly, as special care is needed in these groups. Use in children should be based on a doctor's advice, as there is limited information on its safety and effectiveness in this age group.

Sovateltide is used in the treatment of treatment of ischemic stroke and pulmonary arterial hypertension (PAH). The detailed uses of Sovateltide are as follows:<br/> • Treatment of cerebral ischemic stroke: Sovateltide treats cerebral ischemic stroke by enhancing neuroregeneration and improving blood flow to the affected area of the brain.<br/> • Pulmonary arterial hypertension (PAH): Sovateltide can potentially alleviate Pulmonary Arterial Hypertension (PAH) by relaxing and widening pulmonary arteries, reducing blood pressure.<br/> • Neuroprotection: Sovateltide shields brain cells from damage and enhances mitochondrial function for better energy production.<br/>

When taken consistently as directed, this injection may provide the following health benefits:

• Faster neurological recovery: By stimulating the repair of brain tissues, this medication helps speed up the recovery of motor skills and daily functions.
• Reduced long-term disability: Early treatment can limit the extent of neurological damage, making it easier for patients to regain independence and physical movement.
• Enhanced cellular survival: It protects vulnerable brain cells near the stroke area, preserving vital cognitive and physical abilities.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Sovateltide is administered by the doctor or nurse in a healthcare setting.
• Do not self-administer.

Common Side Effects (Usually mild):

• Headache
• Dizziness
• Redness, pain, or swelling at the injection site
• Mild blood pressure changes

Serious Side Effects (Consult your doctor right away):

• Swelling of the face, lips, tongue, or throat
• Severe breathing difficulties or wheezing
• Sudden, severe chest discomfort or irregular heartbeat